The Board proposes the rule amendment to clarify definitions and to remove obsolete language.

 

DEPARTMENT OF HEALTH
Board of Clinical Laboratory Personnel

RULE NO.: RULE TITLE:
64B3-5.0011: Definitions

PURPOSE AND EFFECT: The Board proposes the rule amendment to clarify definitions and to remove obsolete language.

SUMMARY: Definitions will be clarified and obsolete language will be removed.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION: During discussion of the economic impact of the rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Cost (SERC) was not necessary and that the rule amendment will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time. The Board has determined that this rule will not have an adverse impact on small business, or likely increase regulatory costs in excess of $200,000 in the aggregate within 1 year after implementation of the rule.

Any person who wishes to provide information regarding the statement of estimated costs, or to provide a proposal for a lower regulatory cost alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 483.805, 483.823 FS.
LAW IMPLEMENTED: 483.823 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAW.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Bruce Deterding, Executive Director, Board of Clinical Laboratory Personnel, 4052 Bald Cypress Way, Bin #C07, Tallahassee, Florida 32399-3257

 

THE FULL TEXT OF THE PROPOSED RULE IS:

64B3-5.0011 Definitions.

(1) through (3) No change.

(4) “ABD” means American Board of Dermatology Dentistry.

(5) through (11) No change.

(12) “ABOP” means American Board of Oral Pathology.

(12) through (13) renumbered (13) through (14) No change.

(15)(14)“AOBD” means American Osteopathic Board of Dermatology Dentistry.

(15) through (20) renumbered (16) through (21) No change.

(22)(21)“CAAHEP” means The Commission Council on Accreditation of Allied Health Education Programs.

(22) “CAHEA” means The Committee on Allied Health Education and Accreditation.

(23) “CG” means Cytogenetics

(23) “CLDir” means Clinical Laboratory Director.

(24) “CLS” means Clinical Laboratory Scientist.

(25) through (32) renumbered (24) through (31) No change.

(32) “MB” means Microbiology.

(33) through (43) No change.

(44) “SM” means Specialist in Microbiology.

(44) through (47) renumbered (45) through (48) No change.

(49)(48) “Medical Technology Training Program” means an ABHES, CAAHEP, CAHEA, NAACLS, military or board approved training program for clinical/medical laboratory scientists (CLS) or medical technologists (MT), pursuant to subsections 64B3-2.003(9) and (16), F.A.C., or Department of Defense programs that are equivalent to a board approved training program.

(50)(49) No change.

Rulemaking Authority 483.805, 483.823 FS. Law Implemented 483.823 FS. History–New 6-29-06, Amended 12-16-07, 4-28-10, ________.

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Clinical Laboratory Personnel

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Clinical Laboratory Personnel

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: October 18, 2011

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAW: October 28, 2011